Hypertension and use of bevacizumab among patients treated in community settings.
Volume: 37, Issue: 15_suppl, Pages: e18279 - e18279
Published: May 20, 2019
Abstract
e18279 Background: CancerLinQ Discovery (CLQD) is a real-world dataset (RWD) derived from electronic health records across the US. This analysis builds on the prior observation of cautioned use of bevacizumab (Bev) among older adults using Medicare claims data. The goals of this study are to estimate the prevalence and incidence of hypertension (HT) and blood pressure (BP) patterns among patients (pts) with breast cancer (BC) or lung cancer (LC)...
Paper Details
Title
Hypertension and use of bevacizumab among patients treated in community settings.
Published Date
May 20, 2019
Journal
Volume
37
Issue
15_suppl
Pages
e18279 - e18279
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History